Start: 09 Nov 2021, 16:00
End: 09 Nov 2021, 17:00

Chair: Dr Alastair Greystoke, Newcastle University, UK
Speaker: Dr Anthea Cree, The Clatterbridge Cancer Centre NHS Foundation Trust, UK
Speaker: Ms Alison Fielding, NCRI Consumer Forum, UK
Speaker: Dr Fabio Gomes, The Christie NHS Foundation Trust, UK
Speaker: Dr Shane O'Hanlon, St. Vincent's University Hospital, Ireland

Imagine it’s the year 2035 and we’re about to be hit by a new pandemic…

Changing demographics mean that an increasing number of cancer patients are much older and are likely to have several other health problems. These will impact on the ability to deliver anti-cancer therapies including fitness for therapy, probability of complications and ability to tolerate therapy. In addition, there will be an increasing population of cancer survivors left with residual medical problems from anti-cancer therapy.

At this session, speakers will be encouraged to focus on what should be put in place for the future, examining the problems that could arise, and looking at opportunities for pathway/ workforce redesign to meet these challenges and improve care for the older patient with cancer.

Session labels:

Allied Health Professionals Clinicians Live Living with and beyond cancer Nurses Panel Patient experts Primary Care Physicians Research Administrators Students Trainees / Early career researchers